http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101086895-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate | 2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101086895-B1 |
| titleOfInvention | Pharmaceutical composition comprising sibutramine and thioctic acid |
| abstract | The present invention provides a pharmaceutical composition for the treatment or prevention of obesity and related diseases comprising (a) sibutramine or a pharmaceutically acceptable acid addition salt thereof and (b) thioctic acid or a pharmaceutically acceptable basic salt thereof. It is about. The pharmaceutical composition according to the present invention not only exhibits an excellent synergistic effect on weight loss, but may reduce the side effects of taking sibutramine by reducing the amount of sibutramine.n n n Sibutramine, sibutramine acid addition salt, thioctic acid, thioctic acid basic salt, obesity |
| priorityDate | 2009-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 168.